Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
24.68
-0.84 (-3.29%)
At close: Mar 28, 2024, 4:00 PM
24.42
-0.26 (-1.05%)
After-hours: Mar 28, 2024, 7:59 PM EDT

Immunome Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
98.7820.4249.3339.872.641.7
Short-Term Investments
39.4600000
Cash & Cash Equivalents
138.2420.4249.3339.872.641.7
Cash Growth
576.89%-58.60%23.74%1408.36%55.29%-
Other Current Assets
6.462.237.313.030.480.41
Total Current Assets
144.722.6556.6442.893.122.11
Property, Plant & Equipment
3.640.970.861.531.72.08
Other Long-Term Assets
0.20.430.430.10.240.26
Total Long-Term Assets
3.841.41.291.631.942.34
Total Assets
148.5424.0557.9344.535.064.45
Accounts Payable
3.312.43.081.190.550.47
Deferred Revenue
15.9800000
Current Debt
0000.480.450.61
Other Current Liabilities
2.544.936.651.370.670.48
Total Current Liabilities
21.837.339.733.041.671.56
Long-Term Debt
0000.130.110.56
Other Long-Term Liabilities
6.830.060.010.010.020.02
Total Long-Term Liabilities
6.830.060.010.140.130.58
Total Liabilities
28.667.399.743.181.82.14
Total Debt
0000.610.561.18
Debt Growth
---8.69%-52.04%-
Retained Earnings
-222.81-116-79.11-54.39-36.56-26.11
Comprehensive Income
0.0200000
Shareholders' Equity
119.8816.6548.1941.35-35.63-25.21
Net Cash / Debt
138.2420.4249.3339.252.080.53
Net Cash / Debt Growth
576.89%-58.60%25.67%1788.07%295.25%-
Net Cash Per Share
6.971.684.2811.581.900.08
Working Capital
122.8715.3246.9139.861.460.55
Book Value Per Share
6.041.374.1812.20-32.57-3.87
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).